Farms.com Home   News

Beekeepers Facing Extra Feed Costs

The drought this year had an impact on many Manitoba beekeepers.

Mark Friesen is a beekeeper in the Morden area.

"We are definitely in a situation where this time of year, when there isn't any flowers blooming, that really limits the bees' ability to collect pollen and they need to build up there stores for the winter," he said. "In certain areas, and I'm not saying that's all areas around Morden, we've had quite a bit of a dry stretch, we're going around trying to make sure that they have some supplements to hold on for the winter."

Last week, Manitoba Agriculture Minister Ralph Eichler said that the government is aware of the situation and is reviewing options for support.

"If they do come up with something, that it would be something to supplement our extra feed costs, when we have to go around and feed extra supplement because the bees can't access those flowers that they might have been able to access other years."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.